3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Triple Negative Breast Neoplasms
4
Breast Neoplasms
4
Carcinoma, Non-Small-Cell Lung
3
Urinary Bladder Neoplasms
2
Uterine Cervical Neoplasms
1
Small Cell Lung Carcinoma
1
Recurrence
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Metastatic Solid Tumors
1
Locally Advanced or Metastatic Unresectable Urothelial Cancer
1
Glioblastoma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Hepatocellular
1
Interventions
Cisplatin
13
Radiotherapy, Intensity-Modulated
11
Radiotherapy
5
Carboplatin
5
Radiation
4
Cetuximab
4
durvalumab
3
Platinum
3
Nivolumab
3
1,2-diaminocyclohexaneplatinum II citrate
3
pembrolizumab
2
fludarabine phosphate
2
fludarabine
2
aldesleukin
2
Specimen Handling
2
Restraint, Physical
2
Paclitaxel
2
Fluorodeoxyglucose F18
2
Cyclophosphamide
2
Bupropion
2
Biopsy
2
Acupuncture Therapy
2
veliparib
1
utomilumab
1
sodium thiosulfate
1
ficlatuzumab
1
dehydroftorafur
1
Varenicline
1
Transcutaneous Electric Nerve Stimulation
1
Tobacco Use Cessation Devices
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Oropharyngeal Neoplasms
×
sacituzumab govitecan
×
Clear all
No trials found.